January 16, 2019 — Cerenovus, of Johnson & Johnson Medical Devices Companies, recently launched the EXCELLENT Registry ...
Thrombectomy Devices
This channel includes news and new technology innovations for catheter-based thrombectomy systems used to remove blood clots from vessels in the body. Thrombus removal a decade ago was a standard of care for acute coronary revascularization in ST-elevation myocardial infarction (STEMI). But, its use declined rapidly after several large trials showed no benefit. However today, thrombectomy is seeing increasing usage in new therapeutic areas to treat acute stoke, pulmonary embolism (PE), deep vein thrombosis (DVT) and venous thromboembolism (VTE). Thrombectomy is also referred to as embolectomy.
The types of thrombectomy systems include:
● Ultrasound-assisted thrombolysis – Catheter-directed, high-frequency ultrasound helps thrombolytic agents penetrate clots to speed the action of fibrinolytic pharmacological therapy.
● Rheolytic embolectomy – These devices inject pressurized saline through the catheter's distal tip and the macerated thrombus is aspirated through a catheter port.
● Rotational embolectomy – A rotating device at the catheter tip is used to fragment the clot and fragments are aspirated by the catheter.
● Aspiration thrombectomy – This includes manual clot aspiration or use of dedicated aspiration catheter devices that basically vacuum the clot out of the vessel.
● Thrombus fragmentation – Thrombus can be mechanically disrupted by manually rotating a pigtail catheter or using balloon angioplasty, but this causes small fragments of emboli to flow distally. Dedicated devices also are available.
November 21, 2018 — BTG plc announced the first Ekos CU 4.0 units have been shipped from BTG’s facility in Bothell, Wash ...
May 21, 2018 — Medtronic and the U.S. Food and Drug Administration (FDA) announced a Class I Urgent Medical Device ...
May 11, 2018 — Results of the FlowTriever Pulmonary Embolectomy (FLARE) study were presented as late-breaking clinical ...
February 15, 2018 — The U.S. Food and Drug Administration (FDA) has expanded the indication for Stryker's Trevo ...
January 25, 2018 – Penumbra Inc. today announced results of the company-sponsored PROMISE Study, demonstrating real ...
January 25, 2018 – Advances in brain imaging can identify a greater number of stroke patients who can receive therapy ...
July 7, 2017 — BTG plc recently highlighted the results of the ACCESS PTS trial, presented at the Society for Vascular ...
This video, provided by Ekos, demonstrates the EkoSonic endovascular System thrombolytic system to treat deep vein ...
March 1, 2017 — BTG plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance has been granted to the Ekos ...
January 5, 2017 — A new report published by Allied Market Research forecasts that the global thrombectomy devices market ...
January 2, 2017 — The U.S. Food and Drug Administration (FDA) hopes to build clinical evidence through new registries ...
September 28, 2016 — Neuravi recently announced Conformité Européenne (CE) Mark approval and launch of the company’s ...
July 27, 2016 — Penumbra Inc. announced U.S. commercial availability of its latest thrombectomy device, the ACE68 ...